ARTIA Reconstructive Tissue Matrix Perforated
K-Number: K162752 · 2017-02-24
Device Summary
Frequently Asked Questions
What is the ARTIA Reconstructive Tissue Matrix Perforated?
ARTIA Reconstructive Tissue Matrix Perforated is a medical device that received FDA 510(k) clearance on 2017-02-24. The listed applicant is Lifecell Corporation. The 510(k) number is K162752.
When did ARTIA Reconstructive Tissue Matrix Perforated receive FDA 510(k) clearance?
ARTIA Reconstructive Tissue Matrix Perforated received FDA 510(k) clearance on 2017-02-24, under 510(k) number K162752.
Who is the listed applicant for ARTIA Reconstructive Tissue Matrix Perforated?
The FDA 510(k) record lists Lifecell Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ARTIA Reconstructive Tissue Matrix Perforated?
The FDA product code for ARTIA Reconstructive Tissue Matrix Perforated is FTM.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Lifecell Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: FTM)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.